![Pierluigi Antonelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierluigi Antonelli
Corporate Officer/Principal chez
FRESENIUS SE & CO. KGAA
Profil
Pierluigi Antonelli is currently the Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA. He is also the President & Chief Executive Officer at Fresenius Kabi AG and the Chief Executive Officer at Fresenius Kabi.
Previously, he held the position of Chief Executive Officer at Aziende Chimiche.
Riunite Angelini Francesco - A.C.R.A.F.
- SpA and Angelini Pharma, Inc. From 2019 to 2023, he served as the Chief Executive Officer at Angelini Pharma SpA. He was also the European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA and the Head-Europe Novartis Oncology at Sandoz Deutschland GmbH from 2015 to 2019.
Prior to that, he worked as an Engagement Manager at Mckinsey & Co., Inc. (Munich) from 1994 to 1998 and as a Senior Vice President-Italy at Merck & Co. Mr. Antonelli holds an MBA from Northwestern University, which he obtained in 1994.
He also completed his undergraduate studies at The LUISS University of Rome in 1989.
Postes actifs de Pierluigi Antonelli
| Sociétés | Poste | Début |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/03/2023 |
Fresenius Kabi AG
 Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Directeur Général | - |
Fresenius Kabi | Directeur Général | - |
Anciens postes connus de Pierluigi Antonelli
| Sociétés | Poste | Fin |
|---|---|---|
Angelini Pharma SpA
 Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs | Directeur Général | 06/02/2023 |
Sandoz Deutschland GmbH
 Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | 01/01/2019 |
Mckinsey & Co., Inc. (Munich) | Corporate Officer/Principal | 01/01/1998 |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines | Corporate Officer/Principal | - |
Merck & Co.
 Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Corporate Officer/Principal | - |
Formation de Pierluigi Antonelli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Fresenius Kabi AG
Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The LUISS University of Rome
 The LUISS University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi | |
Sandoz Deutschland GmbH
Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical medicines | Health Technology |
Mckinsey & Co., Inc. (Munich) | |
Angelini Pharma, Inc.
 Angelini Pharma, Inc. Specialty StoresRetail Trade Operates as a medical supply store | Retail Trade |
Merck & Co.
Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Finance |
Angelini Pharma SpA
Angelini Pharma SpA Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
